Key result
Greater day-to-day maximum-minimum systolic blood pressure variability after the first 24 hours of acute ischemic stroke was independently associated with poor functional outcome at 12 months.
Why the study?
Does day-to-day blood pressure variability predict functional outcome in patients with acute ischemic stroke?
Does day-to-day blood pressure variability predict functional outcome in patients with acute ischemic stroke?
Answers are grounded in this paper and cite their sources.
Day-to-day maximum-minimum systolic blood pressure variability after the first 24 hours of acute ischemic stroke is an independent predictor of poor functional outcome at 12 months.
Stroke is a leading cause of death and disability worldwide.1 The prognosis of stroke is highly variable and a large number of studies aimed to identify predictors of outcome in these patients in order to guide treatment decisions.2 Elevated blood pressure (BP) during the acute phase of stroke was an independent predictor of adverse outcome in some reports3,4 but others did not confirm this association.5,6 More recently, focus has shifted to BP variability as a risk factor for cardiovascular morbidity and mortality.7–9 In hypertensive patients and normotensive subjects, increased BP variability appears to increase the risk of cardiovascular events and all-cause mortality independently of clinic or ambulatory BP measurements.7–9 However, there are limited and conflicting data regarding the prognostic significance of BP variability during the acute phase of ischemic stroke.5,10 In this context, a study published in the current issue of the Journal provides new insights in this important topic. Shi et al.11 aimed to evaluate the association between day-to-day BP variability during the first 7 days following acute ischemic stroke and the functional outcome after 12 months. A total of 229 patients admitted within 24 hours after stroke onset were prospectively studied. Patients with recurrent ischemic stroke and substantial pre-existing disability (modified Rankin scale ≥ 2) were excluded from the study. To evaluate BP variability, systolic and diastolic BP was recorded every hour for at least 24 hours and then daily at 7:00 am for the 7 days post stroke. The average interval between stroke onset and the initiation of BP monitoring was 10 hours. Parameters used to assess BP variability during the first 24 hours were the mean, SD, coefficient of variability, and average real variability of both systolic and diastolic BP. During the rest of the hospitalization period, day-to-day BP variability was evaluated with the mean, maximum–minimum, SD and coefficient of variability of both systolic and diastolic BP. The functional outcome was assessed with the modified Rankin Scale at 12 months post stroke. Among the indices of BP variability during the first 24 hours of hospitalization, mean systolic BP as well as mean and SD of diastolic BP correlated with the severity of stroke at admission. Regarding the association between BP variability and functional outcome at 12 months, mean systolic BP during the first 24 hours of hospitalization was higher in patients with poor outcome whereas the other indices of indices of BP variability did not differ between patients with poor and favorable outcome. In contrast, all indices of day-to-day systolic and diastolic BP variability (maximum–minimum, SD, and coefficient of variability) during the subsequent days of hospitalization were higher in patients with poor functional outcome. In logistic regression analysis, the day-to-day maximum–minimum systolic BP after the first 24 hours of hospitalization was independently associated with poor functional outcome at 12 months whereas the other indices of systolic and diastolic BP variability did not predict the outcome. The findings of the present study might have important implications in the management of patients with acute ischemic stroke. First, it appears that BP variability during the first 24 hours of stroke onset is not associated with the long-term outcome of these patients. These findings are also in agreement with recent trials that showed no benefit of reducing BP during the acute phase of ischemic stroke.12–14 Of note, previous studies reported that BP variability during the first 24–72 hours after stroke predicted poor functional outcome at 90 days.5,15,16 However, it is unclear whether the outcome at 90 days is an accurate predictor of longer term outcome. Moreover, the latter studies were retrospective analyses of randomized controlled trials that were performed in selected populations and might not apply to unselected patients with ischemic stroke.5,15,16 Notably, BP variability during the first 72 hours after stroke also does not appear to affect the outcome at discharge.17 Another key finding of the study by Shi et al. is that greater systolic BP variability after the first 24 hours from admission is an independent predictor of adverse functional outcome at 12 months after discharge. Previous studies reported similar findings but only evaluated the functional outcome at 3 months.18,19 Importantly, the only index of BP variability that was independently associated with the functional outcome was the difference between the maximum and minimum systolic BP, i.e., an easily measured parameter in everyday clinical practice. Indeed, several indices of BP variability have been evaluated and many are difficult to calculate and do not appear to provide additional prognostic value.7,10 Given these findings, it is reasonable to hypothesize that the reduction in BP variability during the subacute phase of ischemic stroke might have a beneficial impact on the outcome of these patients. Accordingly, the effects of antihypertensive agents on BP variability might have to be considered in this population and classes that exert greater reductions in BP variability might be more appropriate. Indeed, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm, the greater reduction in the risk of stroke in patients treated with amlodipine than in those treated with atenolol was partly due to the decrease in BP variability in the former and the increase in BP variability in the latter.20 In conclusion, BP variability after the first 24 hours of acute ischemic stroke appears to represent a promising tool for the prediction of long-term outcome. However, larger studies are needed to confirm these findings. If this association is validated, interventional studies using antihypertensive agents with different effects on BP variability are needed to clarify whether decreasing BP variability will translate into better outcomes. The authors declared no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Milonas et al. (2017) conducted an editorial in Acute ischemic stroke (n=229). Day-to-day blood pressure variability was evaluated on Poor functional outcome at 12 months (assessed with the modified Rankin Scale). Greater day-to-day maximum-minimum systolic blood pressure variability after the first 24 hours of acute ischemic stroke was independently associated with poor functional outcome at 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: